Detection of Intron22 Mutations in Iraqi Female Carriers in Wasit Province with Hemophilia A
Keywords:
hemophilia A, factor 8 gene, carriers, intron 22 mutations
Abstract
The background: One of the prevalent main concerns in the medical world is the identification of#xA0; Intron22#xA0; mutations in the Factor VIII gene carried by Iraqi patient in Wasit#xA0;town, in Iraq#xA0;suffering Hemophilia A (#xA0;classical hemophilia)#xA0;which #xA0;is#xA0;related to a #xA0;X-hromosome#xA0;recessive#xA0;haemorrhage#xA0;afflictions as the result of a flaw in the#xA0;coagulation factor#xA0;VIII (FVIII). It is essentially#xA0;related with#xA0;F8 mutations#xA0;of#xA0;Intron22#xA0;inversion#xA0;which forms the most typical kind of#xA0;mutations of#xA0;blood afflictions#xA0;worldwide involving half#xA0;the patients suffering from severe#xA0;Hemophilia A that possesses mutations, in addition to Intron 1#xA0;inversion suffered by 5%#xA0;of severe#xA0;Hemophilia A patients.#xA0;All of the#xA0;inversion mutations are suffered mainly#xA0;by males, and uncommonly by females due to the#xA0;intrachromosomal recombination among the homologous areas, in#xA0;inversion 1#xA0;or#xA0;22, with extragenic copy#xA0;posited the#xA0;telomeric to the Factor VIII#xA0;gene.#xA0;#xA0;Unfortunately, there is an absence#xA0;in#xA0;Iraq#xA0;on researches pertaining#xA0;blood affliction gene#xA0;identification in persons who carries the Intron22 mutations#xA0;exception in#xA0;the current research. Aims of study: The objectives of the research is to to analyze through the detection mechanisms, the existence of#xA0;Intron 22#xA0;mutations in the#xA0;Factor VIII#xA0;gene#xA0;of 10#xA0;#xA0;Hemophilia A#xA0;Iraqi carriers cohort families. The hypothesis and anticipated result is that#xA0;there will be#xA0;a minimal margin of hazardous possibility for#xA0;the recurrence.#xA0;The hereditary F8 mutation#xA0;is#xA0;unknown#xA0;to be present on the maternal side of the patient#xA0;sufferer due to the possibilty#xA0;of germline#xA0;mosaics#xA0;that exists within the#xA0;community. Patients and Methods: The current research involved 10#xA0;Iraqi Hemophilia A carrier, and#xA0;5#xA0;healthy sampling to act as#xA0;the control.This study had utilized#xA0;medicine and science#xA0;school#xA0;labs, with the inclusion#xA0;of AL Karama Teaching Hospital over a time period from#xA0;November, 2016 up to#xA0;January, 2017. The aforementioned respective carriers#xA0;have a previous history of#xA0;diagnosed case history and DNA testing. Results:#xA0;During the whole of the screening duration for Inv22(intron#xA0;twenty two#xA0;inversions) amongst the#xA0;Hemophilia A carriers, the outcomes indicated that 4 out of the 10 carriers#xA0;(40%) suffer from these mutations. Discussion: The research findings highlights on the significance of the Inv22#xA0;analysis and their relationship with positive hereditary case history within the#xA0;#xA0;Hemophilia A carriers, in addition to our ongoing pursuit of seeking for#xA0; Inv1 mutations. Conclusions: The outcomes defines the detrimental influence#xA0;of a diagnosed positive#xA0;family case history and the proximal#xA0;affinity lineage in marriage. There is a dire necessity for Hemophilia A carriers to be given#xA0;specialized and dedicated#xA0;obstetrical#xA0;attention with#xA0;close#xA0;contact with the haemophilia centre, in addition the management#xA0;processes concerning the case should be available#xA0;ought and#xA0;identified. The outcome manifests the pathway towards a genetic guideline. Having the information pertaining the gender of the foetus gender#xA0;is significantly crucial to assist in the supervision of labor, in addition to#xA0;diagnostic processes.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
Published
2017-01-15
Issue
Section
License
Copyright (c) 2017 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.